Look Up > Drugs > Dyclonine
Dyclonine
Pronunciation
U.S. Brand Names
Generic Available
Synonyms
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Overdosage/Toxicology
Drug Interactions
Stability
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Dietary Considerations
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms
References

Pronunciation
(DYE kloe neen)

U.S. Brand Names
Dyclone®; Sucrets®[OTC]

Generic Available

No


Synonyms
Dyclonine Hydrochloride

Pharmacological Index

Local Anesthetic; Local Anesthetic, Oral


Use

Local anesthetic prior to laryngoscopy, bronchoscopy, or endotracheal intubation; use topically for temporary relief of pain associated with oral mucosa or anogenital lesions


Pregnancy Risk Factor

C


Contraindications

Contraindicated in patients allergic to chlorobutanol (preservative used in dyclonine) or dyclonine


Warnings/Precautions

Use with caution in patients with sepsis or traumatized mucosa in the area of application to avoid rapid systemic absorption; may impair swallowing and enhance the danger of aspiration; use with caution in patients with shock or heart block; resuscitative equipment, oxygen, and resuscitative drugs should be immediately available when dyclonine topical solution is administered to mucous membranes; not for injection or ophthalmic use


Adverse Reactions

<1%: Hypotension, bradycardia, respiratory arrest, cardiac arrest, excitation, drowsiness, nervousness, dizziness, seizures, slight irritation and stinging may occur when applied, blurred vision, allergic reactions


Overdosage/Toxicology

Symptoms of overdose are primarily CNS (seizures, excitation) and cardiovascular (hypotension, myocardial depression)

Treatment is supportive with fluids and pressors (particularly those that stimulate the myocardium); diazepam 0.1 mg/kg can be used to control seizures


Drug Interactions

No data reported


Stability

Store in tight, light-resistant containers


Mechanism of Action

Blocks impulses at peripheral nerve endings in skin and mucous membranes by altering cell membrane permeability to ionic transfer


Pharmacodynamics/Kinetics

Onset of local anesthesia: 2-10 minutes

Duration: 30-60 minutes


Usual Dosage

Use the lowest dose needed to provide effective anesthesia

Mouth sores: 5-10 mL of 0.5% or 1% to oral mucosa (swab or swish and then spit) 3-4 times/day as needed; maximum single dose: 200 mg (40 mL of 0.5% solution or 20 mL of 1% solution)

Bronchoscopy: Use 2 mL of the 1% solution or 4 mL of the 0.5% solution sprayed onto the larynx and trachea every 5 minutes until the reflex has been abolished


Dietary Considerations

Food should not be ingested for 60 minutes following application in the mouth or throat area


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

No effects or complications reported


Patient Information

This medication is given to reduce sensation in the injected area. When used in mouth or throat; do not eat or drink anything for at least 1 hour following treatment. Take small sips of water at first to ensure that you can swallow without difficulty. Your tongue and mouth may be numb - use caution to avoid biting yourself. Immediately report swelling of face, lips, tongue; chest pain or palpitations; increased restlessness, confusion, anxiety, or dizziness. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to be pregnant. Consult prescriber if breast-feeding.


Nursing Implications

Use the lowest dose needed to provide effective anesthesia; not for injection; do not apply nasally or to the eye


Dosage Forms

Lozenges, as hydrochloride: 1.2 mg, 3 mg

Solution, topical, as hydrochloride: 0.5% (30 mL); 1% (30 mL)


References

Carnel SB, Blakeslee DB, Oswald SG, et al, "Treatment of Radiation- and Chemotherapy-Induced Stomatitis," Otolaryngol Head Neck Surg, 1990, 102(4):326-30.

Gargiulo AV, Burns GM, and Huck CP, "Dyclonine Hydrochloride - A Topical Agent for Managing Pain," Ill Dent J, 1992, 61(4):303-4.

Nelson LA, "Nonprescription Drug Screening. Dyclonine Hydrochloride," Am Pharm, 1987, NS27(9):27-9.


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved